Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data

By  

Current Pharmaceutical Design, Vol. 21, Iss. 39, 2015-12 ,pp. : 5688-5698

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children

By Krekels Elke H.J.   DeJongh Joost   van Lingen Richard A.  

Clinical Pharmacokinetics, Vol. 50, Iss. 1, 2011-01 ,pp. : 51-63

Adis International

Access to resources Recommend Favorite

Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting

By Sasaki Tomohiro   Tabuchi Hiroko   Higuchi Shun   Ieiri Ichiro  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1257-1266

Future Medicine

Access to resources Recommend Favorite

Developmental Pharmacokinetics of Gentamicin in Preterm and Term Neonates: Population Modelling of a Prospective Study

By Nielsen Elisabet I.   Sandström Marie   >   Ewald Uwe  

Clinical Pharmacokinetics, Vol. 48, Iss. 4, 2009-06 ,pp. : 253-263

Adis International

Access to resources Recommend Favorite

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens

By  

Pharmacology Research & Perspectives, Vol. 6, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite